Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials

[1]  Jennifer K. Sun,et al.  Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to eETDRS Protocol Visual Acuity Assessment. , 2022, Ophthalmology.

[2]  P. Kaiser,et al.  Visual Acuity Variability: Comparing Discrepancies between Snellen and ETDRS Measurements among Subjects Entering Prospective Trials. , 2020, Ophthalmology. Retina.

[3]  David F Williams,et al.  Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States. , 2018, Ophthalmology. Retina.

[4]  David F Williams,et al.  Real-world Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration in the United States. , 2018, Ophthalmology. Retina.

[5]  George A. Williams,et al.  Real-World Vision in Age-Related Macular Degeneration Patients Treated with Single Anti-VEGF Drug Type for 1 Year in the IRIS Registry. , 2017, Ophthalmology.

[6]  J. Jumper,et al.  Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1) , 2017, Clinical ophthalmology.

[7]  B. Vanderbeek,et al.  Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort , 2016, PloS one.

[8]  J. Kowalski,et al.  Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema , 2014, Clinical ophthalmology.

[9]  Christian Simader,et al.  Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. , 2012, Ophthalmology.

[10]  P. Rosenfeld,et al.  NOVEL METHOD FOR ANALYZING SNELLEN VISUAL ACUITY MEASUREMENTS , 2010, Retina.

[11]  Peter K Kaiser,et al.  Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis). , 2009, Transactions of the American Ophthalmological Society.

[12]  W. Freeman,et al.  Comparison of visual acuity in macular degeneration patients measured with snellen and early treatment diabetic retinopathy study charts. , 2008, Ophthalmology.

[13]  Philip J Rosenfeld,et al.  Ranibizumab for neovascular age-related macular degeneration. , 2006, The New England journal of medicine.

[14]  J. Holladay,et al.  Visual acuity measurements. , 2004, Journal of cataract and refractive surgery.